Chinese guidelines on management of hepatic encephalopathy in cirrhosis
Xiao-Yuan Xu1, Hui-Guo Ding2, Wen-Gang Li3
1Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China. xiaoyuanxu6@163.com.
Insights
The Chinese Society of Hepatology released new guidelines for managing hepatic encephalopathy (HE) in cirrhosis patients. Early diagnosis and treatment of minimal hepatic encephalopathy (MHE) are crucial for improving patient outcomes.
Area of Science:
- Hepatology
- Neurology
- Gastroenterology
Background:
- Cirrhosis significantly increases the risk of hepatic encephalopathy (HE), a serious complication affecting brain function.
- Minimal hepatic encephalopathy (MHE) often goes undiagnosed but impacts quality of life and disease progression.
- Current management strategies require updated evidence-based recommendations.
Purpose of the Study:
- To establish comprehensive guidelines for the diagnosis and management of hepatic encephalopathy (HE) in cirrhosis.
- To emphasize the importance of screening for minimal hepatic encephalopathy (MHE) in patients with end-stage liver disease.
- To provide a consensus-based approach for optimizing HE treatment and prevention.
Main Methods:
- Development of guidelines by the Chinese Society of Hepatology.
- Review of published evidence and expert consensus among panelists.
- Formulation of recommendations for diagnosis, treatment, and prevention of HE and MHE.
Main Results:
- Guidelines cover diagnosis and management of both overt HE and MHE.
- Strong emphasis placed on screening MHE in patients with end-stage liver disease.
- Early identification and prompt treatment are highlighted as critical for improved prognosis.
Conclusions:
- Adherence to these guidelines can improve the management of hepatic encephalopathy in cirrhosis.
- Timely intervention and comprehensive treatment principles are essential for better patient outcomes.
- The guidelines provide a framework for primary and secondary prevention of HE recurrence.
Abstract:
The Chinese Society of Hepatology developed the current guidelines on the management of hepatic encephalopathy in cirrhosis based on the published evidence and the panelists' consensus. The guidelines provided recommendations for the diagnosis and management of hepatic encephalopathy (HE) including minimal hepatic encephalopathy (MHE) and overt hepatic encephalopathy, emphasizing the importance on screening MHE in patients with end-stage liver diseases. The guidelines emphasized that early identification and timely treatment are the key to improve the prognosis of HE. The principles of treatment include prompt removal of the cause, recovery of acute neuropsychiatric abnormalities to baseline status, primary prevention, and secondary prevention as soon as possible.
Related Concept Videos
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:28Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations: